- Home
- NEO vs NFJ Comparison
NEO vs NFJ Comparison
Compare NEO & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NEO
- NFJ
- Stock Information
- Founded
- NEO 2001
- NFJ 2005
- Country
- NEO United States
- NFJ United States
- Employees
- NEO N/A
- NFJ N/A
- Industry
- NEO Precision Instruments
- NFJ Finance: Consumer Services
- Sector
- NEO Health Care
- NFJ Finance
- Exchange
- NEO Nasdaq
- NFJ Nasdaq
- Market Cap
- NEO 1.2B
- NFJ 1.2B
- IPO Year
- NEO 1999
- NFJ N/A
- Fundamental
- Price
- NEO $9.55
- NFJ $11.16
- Analyst Decision
- NEO Strong Buy
- NFJ
- Analyst Count
- NEO 10
- NFJ 0
- Target Price
- NEO $19.44
- NFJ N/A
- AVG Volume (30 Days)
- NEO 1.9M
- NFJ 223.5K
- Earning Date
- NEO 04-29-2025
- NFJ 01-01-0001
- Dividend Yield
- NEO N/A
- NFJ 9.01%
- EPS Growth
- NEO N/A
- NFJ N/A
- EPS
- NEO N/A
- NFJ N/A
- Revenue
- NEO $660,566,000.00
- NFJ N/A
- Revenue This Year
- NEO $13.06
- NFJ N/A
- Revenue Next Year
- NEO $11.18
- NFJ N/A
- P/E Ratio
- NEO N/A
- NFJ N/A
- Revenue Growth
- NEO 11.65
- NFJ N/A
- 52 Week Low
- NEO $8.05
- NFJ $10.45
- 52 Week High
- NEO $19.11
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- NEO 48.48
- NFJ 39.34
- Support Level
- NEO $8.05
- NFJ $11.02
- Resistance Level
- NEO $10.18
- NFJ $11.41
- Average True Range (ATR)
- NEO 0.72
- NFJ 0.39
- MACD
- NEO 0.16
- NFJ -0.00
- Stochastic Oscillator
- NEO 70.42
- NFJ 52.53
About NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. Its primary investment objective is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.